Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Materialise NV Q1 2026 Earnings Call - Portfolio Streamlining Drives Margin Expansion Amid Macro Headwinds
Materialise NV delivered a resilient Q1 2026 with stable EUR 66.3M revenue and sharply improved profitability, driven by disciplined cost management and a strategic shift toward higher-margin medical ...
- Revenue held steady at EUR 66.3 million year-over-year, buffered by foreign exchange headwinds.
- Gross margin expanded to 57.2% from 55.3% in Q1 2025, reflecting operational leverage.
- Adjusted EBIT surged to EUR 2.5 million, up from EUR 0.6 million a year earlier.
- +12 more takeaways
CareCloud Inc Q1 2026 Earnings Call - Capital Structure Simplification and AI Product Scaling Drive Revenue Growth
CareCloud reported Q1 2026 revenue of $31.3 million, up 13% year-over-year, driven by strong recurring revenue growth and accelerating adoption of its AI platform. The company delivered its eighth con...
- Revenue grew 13% to $31.3 million in Q1 2026, with recurring technology-enabled business solution revenue rising to $23 million.
- GAAP net income was $922,000, marking the eighth consecutive quarter of profitability, though lower than prior year due to acquisition-related amortization and integration costs.
- Adjusted EBITDA was $5.4 million (17% of revenue), and adjusted net income was $2.2 million, both essentially in line with the prior year.
- +11 more takeaways
Gold Fields Q1 2026 Earnings Call - Production Up 15% Amid Cost Pressures and Geopolitical Headwinds
Gold Fields delivered a solid Q1 2026 with gold equivalent production up 15% year-over-year to 633,000 ounces, driven by strong recoveries at Salares Norte and higher silver prices. However, all-in su...
- Gold equivalent production rose 15% YoY to 633,000 ounces in Q1 2026, supported by Salares Norte’s improved gold and silver recoveries and favorable silver pricing.
- All-in sustaining costs climbed 13% YoY to $1,829/oz, driven by higher royalties, stronger AUD/ZAR, and input inflation, though management maintains full-year cost guidance.
- A $100/bbl oil price scenario adds ~$50/oz to portfolio costs, but mitigation plans and asset optimizations are expected to keep costs within guidance.
- +11 more takeaways
Ironwood Pharmaceuticals Q1 2026 Earnings Call - LINZESS Sales Surge 97% as Apraglutide Progresses
Ironwood Pharmaceuticals delivered a standout first quarter for LINZESS, with U.S. net sales jumping 97% year-over-year to $272.5 million. The surge was fueled by improved net pricing, driven by the e...
- LINZESS U.S. net sales surged 97% year-over-year to $272.5 million in Q1 2026, driven by improved net pricing rather than demand growth.
- Improved net pricing was primarily due to the elimination of inflationary rebates across channels, including Medicaid, and favorable timing of gross-to-net rebate reserves.
- Prescription demand growth for LINZESS was a modest 5% year-over-year, aligning with management's expectation of low single-digit growth for the full year.
- +7 more takeaways
Park-Ohio Holdings Corp. Q1 2026 Earnings Call - Strong Sales Growth Driven by Data Center and Defense Demand, But Southwest Steel Drag Looms
Park-Ohio Holdings reported a solid first quarter in 2026, with sales rising 4% to $421 million and adjusted EPS of $0.65 beating internal expectations. The growth was broad-based, fueled by surging d...
- Sales grew 4% year-over-year to $421 million, with all three business segments reporting sequential and annual growth.
- Adjusted EPS of $0.65 beat internal expectations, driven by higher segment operating income and a lower effective tax rate of 17%.
- Supply Technologies sales rose 4% to $195 million, with semiconductor and data center demand jumping 13% year-over-year.
- +9 more takeaways
Zoetis Q1 2026 Earnings Call - U.S. Companion Animal Revenue Declines Amid Price Sensitivity and Competitive Pressure
Zoetis reported flat organic operational revenue and 1% growth in adjusted net income for Q1 2026, driven by a sharp divergence between international and U.S. performance. International revenue surged...
- U.S. companion animal revenue declined 8% on an organic operational basis, driven by price-sensitive pet owners, reduced clinic visits, and intensified competition in dermatology and parasiticide franchises.
- International revenue grew 10% organically, led by 12% livestock growth and strong emerging market performance, partially offsetting U.S. softness.
- Apoquel and Simparica franchises faced significant share pressure as competitors launched aggressive pricing strategies and generics encroached on legacy products like Convenia and Cerenia.
- +7 more takeaways
Delcath Systems Q1 2026 Earnings Call - CHOPIN Data Drives Volume Growth Amid Slower Site Activations
Delcath Systems reported a strong first quarter 2026, with revenue jumping to $25 million from $19.8 million a year earlier. The growth was fueled by a 36% year-over-year increase in HEPZATO KIT volum...
- Revenue surged 26% year-over-year to $25 million, driven by a 36% increase in HEPZATO KIT volume.
- CHOPIN trial data published in The Lancet Oncology is actively changing prescribing patterns, with response rates improving from 40% to 76% when combined with immunotherapy.
- New patient starts per site remained steady at approximately 0.7 per month, offsetting a slower pace of new center activations.
- +7 more takeaways
Planet Fitness Q1 2026 Earnings Call - Marketing Misfire and Paused Price Hike Drive Guidance Cut
Planet Fitness delivered solid top-line results in Q1 2026, with adjusted EBITDA up nearly 20% and same-club sales growth of 3.5%. But the real story is the membership miss. Net new joins came in at 7...
- Q1 2026 adjusted EBITDA surged 19.5% year-over-year to $140 million, reflecting strong pricing power and franchise fee growth.
- Net new member additions of 700,000 fell short of management’s expectations, with joins driven 90% by rate increases and only 10% by volume.
- Management attributed the membership miss to four factors: a marketing campaign that skewed too heavily toward fitness-minded consumers, regional competition in the Southeast and South Central U.S., severe winter weather, and macroeconomic pressure on lower-income households.
- +7 more takeaways
BCE Inc. Q1 2026 Earnings Call - AI Fabric Drives 113% Growth in Enterprise Solutions
BCE Inc. delivered a mixed Q1 2026 report that underscores a strategic pivot from legacy telecom to high-margin, regulated-avoidant growth vectors. Consolidated revenue rose 4% and adjusted EBITDA gre...
- AI-powered solutions revenue in Bell Business Markets surged 113% year-over-year, pushing total BBM revenue up 9.7% and reinforcing the CAD 2 billion revenue target by 2028.
- Bell AI Fabric is scaling rapidly with four fully contracted facilities, including the newly launched Merritt, B.C. data center, and a CAD 675 million, 300 MW purpose-built facility under construction in Saskatchewan.
- Wireless ARPU fell 0.8% in Q1 due to an unusually aggressive competitive environment, though post-paid net adds remained resilient at nearly 17,000 as management prioritizes lifetime economics over short-term volume.
- +7 more takeaways
Kontoor Brands Q1 2026 Earnings Call - Divesting Lee to Sharpen Focus on Wrangler and Helly Hansen
Kontoor Brands is accelerating a strategic pivot by divesting the Lee brand to concentrate capital and management attention on its two remaining pillars: Wrangler and Helly Hansen. The move, announced...
- Kontoor Brands announced the divestiture of the Lee brand, marking a strategic pivot to focus exclusively on Wrangler and Helly Hansen.
- The decision to sell Lee comes after a multi-year turnaround effort, with management citing improved fundamentals and a favorable sales process timing.
- Helly Hansen contributed 16% pro forma revenue growth in Q1 2026, driven by broad-based strength in sport and workwear segments.
- +7 more takeaways